Paragon Bioservices

(Image: Getty/BrianAJackson)

July roundup sees flurry of partnership deals

By Ben Hargreaves

The summer months are traditionally slow on movements across the industry, but July saw a number of manufacturing partnership deals take place as companies look ahead to product commercialization.

(Image: Getty/vchal)

Catalent bolsters Paragon through Novavax deal

By Vassia Barba

Aiming to boost the gene therapy development and manufacturing capabilities of Paragon, which Catalent acquired in April, the CDMO has agreed to acquire all of the gene therapy-related assets from Novavax, a late-stage vaccine developer.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers